HAASER CHARLES B (VP Fin & Chief Accting Officer) received a stock award from YIELD10 BIOSCIENCE, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/14/2022ACC: 0001179110-22-001144
Officer· VP Fin & Chief Accting Officer
Since Apr 2019
+23.60K
Net shares
Net buyer
$21.5K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
23.60K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5.60K
Price / share
$3.83
Trade value
$21.46K
% of position
81.9%
2/10/2022
6.84K→12.44K
Total
Net shares
+5.60K
Net value
$21.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/10/2022 | A · Award | +5.60K | $3.83 | $21.46K | 81.9% | 6.84K | 12.44K |
| Total | +5.60K | $21.46K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
18K shares
Shares
+18K
Strike price
3.83
Held after
18K
Exercisable
—
2/10/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock18K shares | 2/10/2022 | A · Award | +18K | 3.83 | — | 18K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned5K
Total
5K indirect5K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 5K | Indirect |
| Total | 5K | 5K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported